Drug profile · INN
isoniazid
ARROW PHARMA PTY LTD
isoniazid (ARROW PHARMA PTY LTD) is a enoyl-[acyl-carrier-protein] reductase inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — isoniazid
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 10
- Data quality
- 0.89
Quick answer
isoniazid (ARROW PHARMA PTY LTD) is a enoyl-[acyl-carrier-protein] reductase inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Enoyl-[acyl-carrier-protein] reductase inhibitor
Primary target: Enoyl-[acyl-carrier-protein] reductase [NADH]
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is isoniazid?
isoniazid (ARROW PHARMA PTY LTD) is a enoyl-[acyl-carrier-protein] reductase inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for isoniazid?
ARROW PHARMA PTY LTD is a marketed brand name for isoniazid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of isoniazid?
isoniazid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.